Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Treatment satisfaction in the sensor-augmented pump therapy for A1C reduction 3 (STAR 3) trial.

Peyrot M, Rubin RR; STARĀ 3 Study Group.

Diabet Med. 2013 Apr;30(4):464-7. doi: 10.1111/dme.12079.

PMID:
23496302
2.

Health-related quality of life and treatment satisfaction in the Sensor-Augmented Pump Therapy for A1C Reduction 3 (STAR 3) trial.

Rubin RR, Peyrot M; STAR 3 Study Group.

Diabetes Technol Ther. 2012 Feb;14(2):143-51. doi: 10.1089/dia.2011.0162. Epub 2011 Dec 1.

3.

Sensor-augmented pump therapy for A1C reduction (STAR 3) study: results from the 6-month continuation phase.

Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis SN, Joyce C, Perkins BA, Welsh JB, Willi SM, Wood MA; STAR 3 Study Group.

Diabetes Care. 2011 Nov;34(11):2403-5. doi: 10.2337/dc11-1248. Epub 2011 Sep 20.

4.

Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes.

Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis SN, Joyce C, Peoples T, Perkins BA, Welsh JB, Willi SM, Wood MA; STAR 3 Study Group.

N Engl J Med. 2010 Jul 22;363(4):311-20. doi: 10.1056/NEJMoa1002853. Epub 2010 Jun 29. Erratum in: N Engl J Med. 2010 Sep 9;363(11):1092.

Supplemental Content

Loading ...
Support Center